Childhood Cerebral Anaplastic Astrocytoma
5 clinical trials · Condition
◉ Watch Childhood Cerebral Anaplastic Astrocytoma
| Record | Firm | Date |
|---|---|---|
| Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma (NCT01462695) | National Cancer Institute (NCI) | 2012-01-01 |
| Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma (NCT01236560) | National Cancer Institute (NCI) | 2011-01-26 |
| Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma (NCT00381797) | National Cancer Institute (NCI) | 2006-08-01 |
| AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors (NCT00326664) | National Cancer Institute (NCI) | 2006-03-01 |
| Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors (NCT00919750) | Children's Oncology Group | 2004-02-16 |
Track Childhood Cerebral Anaplastic Astrocytoma automatically
Every clearance here is in the API, with alerts when new ones post.